Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 3Venous Thrombosis 2Venous Thromboembolism 2Lung Neoplasms 2Thromboembolism 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

apixaban 18Dalteparin 15Rivaroxaban 11Enoxaparin 10Heparin, Low-Molecular-Weight 8Aspirin 8Tinzaparin 7Warfarin 3Fondaparinux 3edoxaban 2bemiparin 2abelacimab 2Rosuvastatin Calcium 2Nadroparin 2MAA868 2Dabigatran 2sotorasib 1reviparin 1isoquercitrin 1enoxaparin sodium 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Tacrolimus 1Tablets 1Simvastatin 1Platelet Transfusion 1Phenprocoumon 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Venous Thromboembolism × Nadroparin × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡